CONFERENCE COVERAGE SERIES
Alzheimer's Association International Conference 2013
Boston, MA, U.S.A.
13 – 18 July 2013
Cerebrospinal Fluid Tau Climbs in Aβ Mouse Models
Researchers have detected elevated endogenous tau in the cerebrospinal fluid of Aβ mouse models.
Coverage Denial For Amyloid Scans Riles Alzheimer’s Community
Leaders protest recent decision to deny Medicare beneficiaries coverage of amyloid scans.
Pooled GWAS Reveals New Alzheimer’s Genes and Pathways
At AAIC 2013, researchers present the latest genetic risk factors for Alzheimer's disease.
Are Subtle Memory Concerns a Sign of Future Dementia?
Researchers at AAIC 2013 report that an individual’s subjective sense of worsening memory could be an important predictor of cognitive impairment and dementia.
Clinical Trials Roundup: Four Hits, No Home Runs
Update on compounds in Phase 2 and 3 trials from the Alzheimer's Association International Conference
Clinical Trials Roundup: Broadening the Lines of Attack
Speakers at Alzheimer’s conference reviewed planned Phase 1 and prevention trials and preclinical studies.
Curbing Innate Immunity Boosts Synapses, Cognition
Removing a key component of the innate immune system worsens amyloid deposition but improves memory in mice that model Alzheimer's pathology.
Scientists Hunting Rare Alzheimer’s Mutations Eye Phospholipase D3
Hunting for rare mutations that cause dementia, researchers have spotted, but not yet snagged, some tantalizing candidates.
Biomarkers Predict Alzheimer’s, But Shoe Does Not Always Fit
Studies reported at AAIC demonstrate that biomarkers help predict who will develop cognitive impairment and dementia.
Suspected Non-Amyloid Pathology (SNAP)—Not an Open or Shut Case
AD but no Amyloidβ? Researchers at AAIC 2013 theorized on the pathology underlying this form of dementia.
Dementia Prevalence Falls in England
The proportion of seniors with dementia in England appears to be on the decline, new research suggests.
Are Protein Strains The Cause of Different Tauopathies?
Protein strains may underlie different tauopathies, according to researchers presented at this year's AAIC meeting in Boston.
Tau Tracers Shine at Boston Conference
Tau ligands for PET scans were among the hot topics at the Alzheimer’s Association International Conference in Boston.
Tales of Traveling Tau: Is Transfer Between Neurons Normal?
Is transfer of tau from one neuron to the next a normal activity, hijacked by pathogenic protein in the case of tauopathies?